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and of 17 normal c o n t r o l s . There was no d i f f e r e n c e in morphology and growth r a t e between t h e f i b r o b l a s t s obtained from t h e p a t i e n t s and those from t h e c o n t r o l s . When f i b r ob l a s t s from normal c h i l d r e n were incubated with s e r a of children with I G H D o r LTD, t h e r e was a s i g n i f i c a n t educt i o n in t h e i r protein content and incorporation of 'H-thymidine. When f i b r o b l a s t s obtained from c h i l d r e n with LTD were incubated with t h e p a t i e n t s ' s own serum o r with serum taken from a c h i l d with I G H D , t e r e was a s i g n i f i c a n t reduction in protein content and 'H-thymidine incorporation when compared t o t h a t of f i b r o b l a s t s c u l t u r e d in serum obtained from normal c o n t r o l s o r acromegalic p a t i e n t s . It i s concluded t h a t in p a t i e n t s with I G H D o r LTD f i b r o b l a s t s a r e responsive t o serum growth f a c t o r s .
It would a l s o appear t h a t human serum contains growth f a c t o r s o t h e r than GH-dependent somatomedins.
Z.L. Established I n v e s t i g a t o r of t h e Chief S c i e n t i s t ' s NSILA is a growth hormone dependent serum peptide c l o s e l y r e l a t e d t o the Somatomedins (SM), whose s i g n i f icance as growth hormones has not y e t been c l a r i f i e d i n vivo. Factors involved i n f e t a l growth a r e plentiful, -data suggesting a p o s s i b l e r o l e of SM. Using a s e n s i t i v e competitive p r o t e i n binding a s s a y we.have determined NSILA i n 23 pregnant women and i n 28 paired maternal and cord s e r a . Elean f S.E.V. l e v e l s (pU/ml) during pregnancy (952 f 56) were not s i g n i f i c a n t l y d i f f e r e n t from those i n 8 non-pregnant women (821 f 25) and d i d not change much i n the course of pregnancy. NSILA i n cord serum (597 2 38) was s i g n i f i c a n t l y lower ( p c o . 0 0 1 ) than i n correspondent maternal serum (1039 f 63). Preliminary d a t a i n d i c a t e a r e v e r s e behaviour o f NSILA c a r r i e r protein.
The f i n d i n g of cord NSILA l e v e l s w i t h i n t h e normal c h i l dhood range is compatible w i t h a r o l e i n f e t a l growth.
NSILA carrier p r o t e i n p o s s i b l y c o n t r o l s the r a t e of d i a p l a c e n t a l t r a n s f e r and/or t h e h a l f -l i f e of NSILA i n the f e t u s .
K.W .KASTRUP*~~~ ~.~a p f * (~n t r . by H. Andersen), 33 Childrens Hospital, F'uglebakken, Copenhagen, Denmark and Kantonsspital , Z i i r i c h ,~c h w i t z e r l a n d . Nonsuppressible Insulin-Like A c t i v i t y (NSILA) and . Somatomedin (SM) i n Laron's Syndrome.
I n attempt t o compare l e v e l s of NSILA and SM and study t h e s u l f a t i o n a c t i v i t y o f p u r i f i e d NSILA i n a condition with low SM, NSILA was determined i n a boy with high IR-HGH and low S M ( 2 8 u / m l (norm.range f o r age .91*15)).
NSILA i n bioassa ( f a t pad) was below 2 5 p~/ m l (norm.range 160137). I n a sp$cific c a r r i e r r o t e i n bindin a s s NSILA was 23 (rU/ml (norm.range 3 4~6 ; ) , (hypopi t . r L g e z 3 2 2 7 ) . The preparation of NSILA was obtained by Sephadex G-50 chromatography of serum i n 1 M a c e t i c a c i d . The a c t i v i t y o f concentrations i n range of 5-40 (ru/ml i n medium alone was very low, whereas a s i g n i f i c a n t increased a c t i v i t y p a r a l l e l t o t h a t of normal serum could be demonstrated i n t h e presence of t h e p a t i e n t s serum. This was not l i m i t e d by t h e concentration of serum a s 10 % and 20 % serum gave i d e n t i c a l curves. Analogy between NSILA and S M i n t h i s condition is t h u s demonstrated and furthermore t h a t t h e low S M a c t i v i t y can be enhanced by a d d i t i o n of NSILA not excluding t h e presence of a growth hormone independent s t i m u l a t i n g f a c t o r i n serum. P. ROCHICCIOLI*, G. DUTAU*, D. AUGIER*, P. ENJAUME*, (Intr.
by R. RAPPAPORT).
chu Rangueil -Toulouse, France.
Report on a mass screening program (14,000 samples) for neonatal hypothroidism using a filter paper T4 and TSH method. From January 1976 to April 1977,14,000 newborns were screened in the district of Midi-Pyrenees. The screening program detected 4 cases of neonatal hypothyroidism (113500) with T4 35 pgJ2 spots and TSH 200 uU/2 spots. At 20 days of age T4 levels were under 2,8 ug/dl and TSH reached more than 40 uU/ml. The T3 levels were low in 3 cases but normal in 1 case (150ngJdl). Thyroid scintigram (Tc 99 m) showed no gland for the four cases. On the fourth week, the neonatal symptoms of hypothyroidism were nearly absent, except mottlings in two cases, a large posterior fontanelle in two cases and a physiological jaundice in one case. A thyroid extracts treatment was started in the four cases since.the 30th day. Now, in the oldest child, after 13 months of treatment, the mental development is normal (IQ : 110).
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35 SCHERZ*. Department of Pediatrics, University Zurich, and Central Laboratory Tranfusion Service, SRC, Berne, Switzerland.
Detection of neonatal hypothyroidism in Switzerland by TSH determination using filter paper blood samples.
TSH radioimmunoassay has been adapted for the determination in dried blood spotted on filter paper (disc @ 6.5mm = 10 , I J I blood, sensitivity 12 .uU/ml, processing time 40 hours). This test has been introduced in our screening program for metabolic d i - Of 18'800 infants tested routinely on their 5th day of life, seven cases with primary hypothyroidism were discovered owing to excessive blood TSH ( 100pU/ml). The diagnosis was not recognized clinically although all 7 infants showed some symptoms. T4 therapy has been started within their second week of life. There were no false positive results. The incidence of 1 in 2700 newborns is higher than reported so far. It has to be shown whether this is due to genetic or geographic factors, to the occurance of transitory forms, or to a more complete ascertainment by the TSH (versus T4) assoy.
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) . Endocrinology Division Hospital f o r Sick Children, and Department of Medicine, Mount S i n a i Hospital, Toronto, Canada. Cord blood screening f o r congenital hypothyroidism.
A r e g i o n a l i s e d screening programme f o r neonatal hypothyroidism using umbilical cord blood has been developed. An i n i t i a l serum thyroxine (Tq) was performed on a l l i n f a n t s and supplementary t h y r o t r o p i n (TSH) measurements were made only on those samples where Tq was < 1 0 t h % i l e . I n f a n t s (<0.2%) with low Tq but serum TSH >50 v U / m l were r e c a l l e d . I n 38,000 b i r t h s 14 detected c a s e s had'thyroid dysfunction (TD) confirmed by t h y r o i d a l r a d i o i o d i n e uptake (RAI) . Primary TD occurred i n 13:-Athyrosis 4, Dyshormonogenesis 3, Hypoplasia 3, Lingual thyroid 2, Iodide induced 1; and secondary i n 1 case. Without t h e hypop l a s i a c a s e s (where " s u b c l i n i c a l hypothyroidism" was present on follow up: normal Tq, abnormal RAI, and elevated TSH) and t h e secondary case, t h e incidence of s i g n i f i c a n t primary hypothyroidism (SPH) was 1 i n 4,000. Treatment with L-thyroxine 5.0 pglkglday was begun day of l i f e 25-83 i n t h e 10 SPH c a s e s with 8 t r e a t e d before 5 weeks and 5 before 4 weeks of age. A high incidence of c o n g e n i t a l hypothyroidism has been documented, and t h e e f f e c t i v e n e s s of cord blood screening f o r i t s e a r l y d e t e c t i o n and treatment demonstrated.
